Insife was proud to participate in the DIA Global Pharmacovigilance and Risk Management Strategies Conference. This conference brought together experts from around the world to discuss the latest trends and best practices in drug safety and risk management.
Insife's representatives, Jen Markey and Wilfred Gilich, were present at booth 211 to showcase HALOPV's features and benefits. HALOPV is Insife’s revolutionary platform that manages all drug and device processes from operational to scientific, in the world’s first fully comprehensive and cohesive solution.
One of the most valuable aspects of the conference was the opportunity to connect with attendees and answer their questions. We were impressed by the level of interest in HALOPV's capabilities, and we were happy to provide further information and guidance to help attendees understand how HALOPV can help improve their drug safety processes.
With its extensive coverage and user-friendly interface, HALOPV makes it easy for you to access and analyze safety data, automate processes, and integrate your data. By using HALOPV, you can execute all global pharmacovigilance activities through a single application, while eliminating time spent getting the data to the right people and into the right places.
Here’s what Jen Markey, Insife's representative, had to say: “It was great to be at the DIA Risk Management conference again after many years for me personally. I really enjoyed hearing the update from the MHRA on their SafetyConnect programme and how HALO is being used as part of that initiative”.
We're excited to continue to help our clients stay compliant with global regulations while streamlining their drug safety processes with HALOPV.
To learn more about HALOPV or our other solutions and services, contact info@insife.com.
